{"meta":{"page":1,"per_page":50,"max_per_page":100,"total":7,"total_is_capped":false,"direct_labels_cover":0,"predictions_cover":7,"direct_label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline (scores rank; they never assert a category)","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"query_hash":"ca8eed8d22fc","filters":{"venue":"Human Gene Therapy Clinical Development"}},"results":[{"id":"W2789451500","doi":"10.1089/humc.2017.249","title":"A Multicenter, Double-Blind, Phase III Clinical Trial to Evaluate the Efficacy and Safety of a Cell and Gene Therapy in Knee Osteoarthritis Patients","year":2018,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":115,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"WOMAC; Medicine; Osteoarthritis; Visual analogue scale; Placebo; Knee pain; Clinical trial; Internal medicine; Patella; Adverse effect; Urology; Physical therapy; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.1310568444743981,"gpt":0.4169022474667948,"spread":0.2858454029923968,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002530967,0.0003901233,0.001026104,0.0001485813,0.0002400317,0.00003782938,0.0001803442,0.0002458362,0.0001606785],"category_scores_gemma":[0.00008264091,0.0002679455,0.0001755273,0.0001897242,0.0003769899,0.00005943622,0.0001560477,0.000312937,0.00002994305],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00004973157,"about_ca_system_score_gemma":0.0002459096,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001323564,"about_ca_topic_score_gemma":0.00008929815,"domain_scores_codex":[0.9955544,0.0004384131,0.002256959,0.0007881821,0.0005037065,0.000458331],"domain_scores_gemma":[0.9980807,0.0004193383,0.0003019949,0.0005298455,0.0002650234,0.0004030859],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.4062214,0.005261789,0.007972418,0.00000719463,0.0001431721,0.00001661387,0.001839627,4.547633e-8,0.004189043,0.00000960231,0.0000233196,0.5743157],"study_design_scores_gemma":[0.8477679,0.06949244,0.05356655,0.0001545984,0.00006662541,0.000004801152,0.00005741094,0.000002976397,0.02316391,0.00003026273,0.005393756,0.0002987633],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.991046,0.001218234,0.00001611204,0.0001510025,0.0006725023,0.006699387,0.00001041973,0.00003268648,0.0001537237],"genre_scores_gemma":[0.9923244,0.002955118,0.002459933,0.001132807,0.000500508,0.0002854118,0.00008218037,0.00005125352,0.0002084076],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.574017,"threshold_uncertainty_score":0.9999773,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2963380471","doi":"10.1089/humc.2018.201","title":"The Landscape of Cellular and Gene Therapy Products: Authorization, Discontinuations, and Cost","year":2019,"lang":"en","type":"review","venue":"Human Gene Therapy Clinical Development","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":81,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Authorization; Cell therapy; Medicine; Genetic enhancement; Food and drug administration; Stem-cell therapy; Business; Pharmacology; Cell; Internal medicine; Gene; Biology; Computer science","retraction":null,"screen_n_in":null,"score":{"opus":0.2059871115335652,"gpt":0.4292700288717852,"spread":0.22328291733822,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002584667,0.0003390382,0.001338753,0.0001046317,0.0002914206,0.00005144854,0.0001680851,0.0005146618,0.00004153134],"category_scores_gemma":[0.0000975053,0.0001796813,0.0001583447,0.0002356253,0.0006849369,0.00002772397,0.0000859443,0.000479945,0.000007088845],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003000341,"about_ca_system_score_gemma":0.0009007491,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002260547,"about_ca_topic_score_gemma":0.000002491699,"domain_scores_codex":[0.9967697,0.0003336513,0.001645944,0.0005723186,0.0004518925,0.0002264762],"domain_scores_gemma":[0.9980121,0.0004017512,0.0006868616,0.0004786701,0.0002640688,0.0001565247],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00004279517,0.0001514437,0.0001804349,0.00111366,0.0004409312,0.000001670736,0.000215138,3.092252e-8,0.0000850815,0.0006678437,0.0002708477,0.9968301],"study_design_scores_gemma":[0.001524832,0.0003354153,0.004867748,0.001509602,0.0001692134,0.0000116471,0.00001494509,0.000006466957,0.0001252444,0.0002159418,0.9909765,0.0002424395],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002068253,0.9937776,0.0002857623,0.001023424,0.0003549821,0.002398668,0.000009374616,0.00002281169,0.00005917321],"genre_scores_gemma":[0.0006005579,0.9953219,0.00104689,0.0001414505,0.0004132342,0.00009843701,0.0006069952,0.00005207023,0.001718507],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9965877,"threshold_uncertainty_score":0.7327192,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2323323362","doi":"10.1089/humc.2014.154","title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","year":2015,"lang":"en","type":"review","venue":"Human Gene Therapy Clinical Development","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute; National Institute of Environmental Health Sciences; Canadian Institutes of Health Research; National Institutes of Health; Cystic Fibrosis Foundation","keywords":"Cystic fibrosis; Genetic enhancement; Disease; Biology; Phenotype; Gene; Animal model; Gene delivery; Viral vector; Bioinformatics; Recombinant DNA; Computational biology; Cancer research; Medicine; Pathology; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.2275643592302552,"gpt":0.4447940573641431,"spread":0.217229698133888,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002606164,0.0007555541,0.002007601,0.0001477591,0.0001925957,0.0000662516,0.0005756857,0.0007306887,0.00001768428],"category_scores_gemma":[0.00006478535,0.0005944872,0.0003897862,0.0001361773,0.0003690271,0.000008335358,0.0002788985,0.0003171195,0.000003785189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006186926,"about_ca_system_score_gemma":0.001560645,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002883035,"about_ca_topic_score_gemma":0.00001358316,"domain_scores_codex":[0.9955288,0.0005085632,0.001656703,0.001287487,0.0004273945,0.0005910898],"domain_scores_gemma":[0.9976725,0.0001286843,0.0006078461,0.0008527249,0.0003528111,0.0003854496],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.002985922,0.0005725665,0.00002226268,0.001930955,0.001284551,0.000004567381,0.0001844235,0.000003778787,0.006540893,0.00002166848,0.0005549007,0.9858935],"study_design_scores_gemma":[0.007695511,0.01581884,0.00007888523,0.001481352,0.0001717389,0.00004028085,0.00001359475,0.00002381274,0.02214333,0.001342251,0.9497098,0.001480647],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.08016834,0.9155582,0.0001745868,0.000015916,0.0001066914,0.003822347,0.00009774675,0.00002309155,0.0000331434],"genre_scores_gemma":[0.001137796,0.9899283,0.005820225,0.0001193309,0.0004340624,0.001165039,0.0007015793,0.0001832537,0.0005104356],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.9844128,"threshold_uncertainty_score":0.9996507,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W1920785403","doi":"10.1089/humc.2014.145","title":"A Multicenter, Single-Blind, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of a Cell-Mediated Gene Therapy in Degenerative Knee Arthritis Patients","year":2015,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true},"ca_institutions":"","funders":"","keywords":"Osteoarthritis; WOMAC; Medicine; Cartilage; Adverse effect; Visual analogue scale; Clinical endpoint; Internal medicine; Randomized controlled trial; Arthritis; Surgery; Pathology","retraction":null,"screen_n_in":null,"score":{"opus":0.196832391785746,"gpt":0.416537915641443,"spread":0.219705523855697,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003252028,0.0004544728,0.001208262,0.0001779881,0.0001587294,0.00003794208,0.0002149295,0.0002812196,0.00009326458],"category_scores_gemma":[0.0004667412,0.0003122914,0.0002335113,0.0002802879,0.000226759,0.00006719208,0.0001316848,0.0003800367,0.00004995203],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001350126,"about_ca_system_score_gemma":0.0005676504,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001039242,"about_ca_topic_score_gemma":0.00008353279,"domain_scores_codex":[0.9942656,0.0009968211,0.002694365,0.0007990064,0.0007362526,0.0005080035],"domain_scores_gemma":[0.9973997,0.0005987415,0.000394766,0.0005352743,0.0004366648,0.0006348672],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.3214864,0.0230577,0.01194458,0.000007647312,0.000421278,0.00007114751,0.005310006,0.000002523809,0.0165757,0.000009954078,0.0002294874,0.6208836],"study_design_scores_gemma":[0.8481233,0.06844759,0.03004294,0.0001885636,0.00006863921,0.000004541147,0.0001486336,0.00001908833,0.04712236,0.00004042666,0.005350797,0.0004431323],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9911048,0.001577885,0.00005165526,0.0002837526,0.0008330552,0.005995876,0.0000242358,0.000044501,0.00008423011],"genre_scores_gemma":[0.9903979,0.002351749,0.004520865,0.001452482,0.0003990121,0.0003439616,0.0003212472,0.00006360668,0.0001492072],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6204404,"threshold_uncertainty_score":0.9999329,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W4255681473","doi":"10.1089/hum.2014.154","title":"Ferret and Pig Models of Cystic Fibrosis: Prospects and Promise for Gene Therapy","year":2014,"lang":"en","type":"article","venue":"Human Gene Therapy Clinical Development","topic":"Animal Genetics and Reproduction","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institutes of Health","keywords":"Cystic fibrosis; Genetic enhancement; Medicine; Gene; Biology; Internal medicine; Genetics","retraction":null,"screen_n_in":null,"score":{"opus":0.06083135663043778,"gpt":0.3244637290561704,"spread":0.2636323724257326,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007122562,0.0001885404,0.0002806179,0.0000278505,0.0001375924,0.00002108788,0.0001097848,0.0001594463,0.000004260582],"category_scores_gemma":[0.0000316,0.0001511403,0.00006892658,0.00003151446,0.0001511122,0.000003540896,0.000070961,0.00005979673,5.502493e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005932421,"about_ca_system_score_gemma":0.00007405849,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000002210459,"about_ca_topic_score_gemma":0.000003175859,"domain_scores_codex":[0.9985414,0.00007120114,0.0005034498,0.000575259,0.0001108716,0.0001978647],"domain_scores_gemma":[0.9993108,0.00002266143,0.0001641257,0.0002816862,0.0001204322,0.0001003135],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0008346123,0.0003002727,0.002257633,0.00004235884,0.0001616693,2.534635e-7,0.0002315407,0.00003765553,0.9477216,0.00021243,0.00014257,0.04805742],"study_design_scores_gemma":[0.004538557,0.005083698,0.07578205,0.00003482035,0.00002106293,0.00001173976,0.00002118607,0.000370205,0.8846392,0.003979068,0.0250365,0.0004818943],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9891313,0.004886497,0.005062837,0.00006630208,0.00009170213,0.0006951574,0.000005019687,0.00001075958,0.00005036978],"genre_scores_gemma":[0.9761526,0.004600854,0.01818911,0.0001692097,0.0003403589,0.00009986531,0.00005640699,0.0000328213,0.0003587859],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07352442,"threshold_uncertainty_score":0.6163323,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2420725116","doi":"10.1089/humc.2016.29012.kod","title":"Sequenom, the U.S. Supreme Court, and Personalized Medicine","year":2016,"lang":"en","type":"editorial","venue":"Human Gene Therapy Clinical Development","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Dawson College","funders":"","keywords":"Supreme court; Personalized medicine; Law; Political science; Library science; Computer science; Bioinformatics; Biology","retraction":null,"screen_n_in":null,"score":{"opus":0.1068672157951746,"gpt":0.420018691384724,"spread":0.3131514755895494,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["sts","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004572698,0.0004872148,0.001164154,0.0001115443,0.0004207825,0.00003289786,0.0003329251,0.001710524,0.001302653],"category_scores_gemma":[0.0004320685,0.0002242214,0.0002028196,0.0001073069,0.003805175,0.00002561716,0.0001445838,0.001553702,0.00004844083],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001705896,"about_ca_system_score_gemma":0.001561576,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002258596,"about_ca_topic_score_gemma":0.00001872099,"domain_scores_codex":[0.9951843,0.0003369166,0.001520381,0.0008013283,0.001735072,0.0004220037],"domain_scores_gemma":[0.9963883,0.001607614,0.0004811943,0.0006010859,0.0004920792,0.0004297025],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004687199,0.0001380646,0.00008039393,0.00009853199,0.0006700399,0.00003262187,0.0008138546,9.670844e-9,0.0006952654,0.0004509463,0.9251804,0.0713711],"study_design_scores_gemma":[0.006939513,0.0006945298,0.005006795,0.0006742188,0.0001188297,0.00001249195,0.0000229334,0.000002179857,0.00006102375,0.002330111,0.9838127,0.0003246422],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"editorial","genre_scores_codex":[0.01006123,0.02061573,0.0004394003,0.07903447,0.8846262,0.00243274,0.00005796178,0.0002419031,0.002490358],"genre_scores_gemma":[0.002993281,0.03478916,0.0008519542,0.003564875,0.9376875,0.00009670007,0.0009231646,0.0001357934,0.01895764],"genre_candidate":"editorial","genre_consensus":"editorial","teacher_disagreement_score":0.07546959,"threshold_uncertainty_score":0.9996103,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null},{"id":"W2562765584","doi":"10.1089/humc.2016.29019.per","title":"User-Friendly Technology the Key to Gene-Editing's Bloom: Market for Gene-Editing Tools Estimated at $608m and Growing as New Applications Are Found","year":2016,"lang":"en","type":"editorial","venue":"Human Gene Therapy Clinical Development","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false},"ca_institutions":"Innovation, Science and Economic Development Canada","funders":"","keywords":"Key (lock); User Friendly; Genome editing; Computer science; Gene; Download; World Wide Web; Biology; Genetics; CRISPR; Operating system","retraction":null,"screen_n_in":null,"score":{"opus":0.03171068162398359,"gpt":0.382900122455972,"spread":0.3511894408319884,"validation_status":"score_only:v0-immature-baseline"},"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001135601,0.000672351,0.0007134394,0.0001429721,0.0007009961,0.0001493721,0.0009097509,0.001258782,0.00006197363],"category_scores_gemma":[0.001181076,0.0005370643,0.0002362284,0.0001603425,0.0001804801,0.00001014269,0.0006833305,0.0004314915,0.00002812517],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001117745,"about_ca_system_score_gemma":0.0005924644,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007070904,"about_ca_topic_score_gemma":0.00006627964,"domain_scores_codex":[0.9960621,0.00008743441,0.001270729,0.001384906,0.0004302309,0.0007646179],"domain_scores_gemma":[0.9972837,0.0005060169,0.0004875723,0.0009632751,0.0003595231,0.0003999383],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002605949,0.00008932573,0.0004706991,0.00007348707,0.0006849511,0.000008515462,0.00009592144,0.00003946308,0.09187182,0.00002808548,0.854928,0.05144913],"study_design_scores_gemma":[0.001745852,0.0003908931,0.0007028283,0.0001199549,0.00006491048,0.00001724621,0.00003243654,0.000005139677,0.09192748,0.0001242307,0.9042342,0.0006348612],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"editorial","genre_scores_codex":[0.5486351,0.01592757,0.1484583,0.004050788,0.2706369,0.01006609,0.00103401,0.0005887034,0.000602545],"genre_scores_gemma":[0.008403012,0.006581111,0.1153051,0.001840837,0.8423712,0.004593625,0.00338598,0.0006722341,0.01684696],"genre_candidate":"editorial","genre_consensus":null,"teacher_disagreement_score":0.5717342,"threshold_uncertainty_score":0.9997081,"prediction_status":"machine_predicted_unvalidated"},"labels":[],"label_agreement":null}]}